{"transactions":[{"id":4618064,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Business"}}],"security":"Common Stock","published_at":"2026-09-15T20:24:25.000Z","date":"2026-09-11","kind":"sale","planned":false,"acquired":false,"shares":5691,"price":92.95,"value":528978.45,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001783992-26-000006","document":"form4-09152026_080921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783992/000178399226000006/form4-09152026_080921.xml","form_type":"4"}},{"id":697700,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Business"}}],"security":"Restricted Stock Units","published_at":"2026-08-04T20:18:14.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":false,"shares":9957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the RSUs vested on August 1, 2026.  The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the RSUs vested on August 1, 2026.  The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028."}],"balance_after":19913,"derivative":{"underlying":"Common Stock","underlying_shares":9957},"source":{"system":"sec-edgar","filing":"0001783992-26-000004","document":"form4-08042026_080809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000178399226000004/form4-08042026_080809.xml","form_type":"4"}},{"id":697699,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Business"}}],"security":"Common Stock","published_at":"2026-08-04T20:18:14.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4266,"price":92.68,"value":395372.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by Zimmer Biomet Holdings, Inc. (the \"Company\") to satisfy tax withholding obligations on the vesting of restricted stock units (\"RSUs\")."}],"balance_after":5691,"source":{"system":"sec-edgar","filing":"0001783992-26-000004","document":"form4-08042026_080809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000178399226000004/form4-08042026_080809.xml","form_type":"4"}},{"id":697698,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Business"}}],"security":"Common Stock","published_at":"2026-08-04T20:18:14.000Z","date":"2026-08-01","kind":"exercise","planned":false,"acquired":true,"shares":9957,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9957,"source":{"system":"sec-edgar","filing":"0001783992-26-000004","document":"form4-08042026_080809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000178399226000004/form4-08042026_080809.xml","form_type":"4"}},{"id":885608,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Business"}}],"security":"Restricted Stock Units","published_at":"2026-02-25T02:02:45.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":27385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests annually over three years in increments of one-third each year, commencing February 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests annually over three years in increments of one-third each year, commencing February 20, 2027."}],"balance_after":27385,"derivative":{"underlying":"Common Stock","underlying_shares":27385},"source":{"system":"sec-edgar","filing":"0001783992-26-000002","document":"form4-02252026_020242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000178399226000002/form4-02252026_020242.xml","form_type":"4"}},{"id":1068110,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Grp Pres-Global Bus."}}],"security":"Restricted Stock Units","published_at":"2025-08-13T20:15:14.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":29870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the RSUs shall vest on each of August 1, 2026, August 1, 2027 and August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third of the RSUs shall vest on each of August 1, 2026, August 1, 2027 and August 1, 2028."}],"balance_after":29870,"derivative":{"underlying":"Common Stock","underlying_shares":29870},"source":{"system":"sec-edgar","filing":"0001062993-25-014300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299325014300/form4.xml","form_type":"4"}},{"id":1179406,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-04-03T16:30:30.000Z","date":"2025-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":852337,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus (\"Merger Sub\"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the \"Merger Consideration\"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-050465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000095017025050465/ownership.xml","form_type":"4"}},{"id":1212015,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-11T17:23:43.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":27029,"price":5.77,"value":155957.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 156,897 restricted stock units."}],"balance_after":216133,"source":{"system":"sec-edgar","filing":"0001444380-25-000041","document":"wk-form4_1741728217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000144438025000041/wk-form4_1741728217.xml","form_type":"4"}},{"id":1294381,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-27T16:17:05.000Z","date":"2025-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":6685,"price":5.16,"value":34494.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 207,091 restricted stock units."}],"balance_after":243162,"source":{"system":"sec-edgar","filing":"0001444380-25-000014","document":"wk-form4_1738012618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000144438025000014/wk-form4_1738012618.xml","form_type":"4"}},{"id":1380611,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-10-28T16:06:10.000Z","date":"2024-10-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":6063,"price":4.85,"value":29405.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 218,393 restricted stock units."}],"balance_after":249847,"source":{"system":"sec-edgar","filing":"0001610717-24-000515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000515/form4.xml","form_type":"4"}},{"id":1448024,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-26T16:43:40.000Z","date":"2024-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":6061,"price":9.74,"value":59034.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 229,695 restricted stock units."}],"balance_after":255910,"source":{"system":"sec-edgar","filing":"0001610717-24-000409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000409/form4.xml","form_type":"4"}},{"id":1534690,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-26T17:00:55.000Z","date":"2024-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":24233,"price":12.51,"value":303154.83,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 240,996 restricted stock units."}],"balance_after":261971,"source":{"system":"sec-edgar","filing":"0001610717-24-000226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000226/form4.xml","form_type":"4"}},{"id":1583997,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-03-11T16:53:52.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":150581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on March 7, 2025 and the remainder will vest quarterly thereafter, such that all RSUs will be fully vested by the third anniversary of the grant date, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 286,204 RSUs."}],"balance_after":286204,"source":{"system":"sec-edgar","filing":"0001610717-24-000148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000148/form4.xml","form_type":"4"}},{"id":1913300,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-04-26T17:55:28.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":135623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. 1/3rd of the RSUs will vest on April 24, 2024 (the \"Anniversary Date\"), and 1/12th of the RSUs will vest in equal quarterly installments thereafter following the Anniversary Date, such that all RSUs will have vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 135,623 RSUs."}],"balance_after":135623,"source":{"system":"sec-edgar","filing":"0001610717-23-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071723000031/form4.xml","form_type":"4"}},{"id":2113287,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-11-17T21:29:05.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":12490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":40.85,"expiration_date":"2027-12-01","underlying":"Common Stock","underlying_shares":12490},"source":{"system":"sec-edgar","filing":"0001127602-22-025948","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025948/form4.xml","form_type":"4"}},{"id":2113286,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-17T21:29:05.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":12490,"price":75.301,"value":940509.49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $75.26 to $75.372 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":62368,"source":{"system":"sec-edgar","filing":"0001127602-22-025948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025948/form4.xml","form_type":"4"}},{"id":2113285,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-17T21:29:05.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":12490,"price":40.85,"value":510216.5,"ownership":{"direct":true},"balance_after":74858,"source":{"system":"sec-edgar","filing":"0001127602-22-025948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025948/form4.xml","form_type":"4"}},{"id":2113284,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-17T21:29:05.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":6628,"price":75.37,"value":499552.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $75.35 to $75.40 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":62368,"source":{"system":"sec-edgar","filing":"0001127602-22-025948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025948/form4.xml","form_type":"4"}},{"id":2119069,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-14T21:43:35.000Z","date":"2022-11-11","kind":"tax_withholding","acquired":false,"shares":8780,"price":75.93,"value":666665.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied."}],"balance_after":68996,"source":{"system":"sec-edgar","filing":"0001127602-22-025497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025497/form4.xml","form_type":"4"}},{"id":2119068,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-14T21:43:35.000Z","date":"2022-11-09","kind":"tax_withholding","acquired":false,"shares":591,"price":72.11,"value":42617.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied."}],"balance_after":77776,"source":{"system":"sec-edgar","filing":"0001127602-22-025497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025497/form4.xml","form_type":"4"}},{"id":2121670,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-11-09T22:13:30.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":19327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 7, 2022."}],"balance_after":19327,"derivative":{"exercise_price":74.35,"expiration_date":"2032-11-07","underlying":"Common Stock","underlying_shares":19327},"source":{"system":"sec-edgar","filing":"0001127602-22-025217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025217/form4.xml","form_type":"4"}},{"id":2121669,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-09T22:13:30.000Z","date":"2022-11-08","kind":"tax_withholding","acquired":false,"shares":709,"price":73.71,"value":52260.39,"ownership":{"direct":true},"balance_after":78367,"source":{"system":"sec-edgar","filing":"0001127602-22-025217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025217/form4.xml","form_type":"4"}},{"id":2121668,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Group Pres, Global Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-09T22:13:30.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":6724,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":79076,"source":{"system":"sec-edgar","filing":"0001127602-22-025217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222025217/form4.xml","form_type":"4"}},{"id":2126448,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2022-11-03T20:46:48.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":12277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Performance stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":72352,"source":{"system":"sec-edgar","filing":"0001127602-22-024911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760222024911/form4.xml","form_type":"4"}},{"id":2513814,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2021-11-15T21:21:23.000Z","date":"2021-11-12","kind":"tax_withholding","acquired":false,"shares":6833,"price":73.54,"value":502498.82,"ownership":{"direct":true},"balance_after":60075,"source":{"system":"sec-edgar","filing":"0001127602-21-029115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221029115/form4.xml","form_type":"4"}},{"id":2513813,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2021-11-15T21:21:23.000Z","date":"2021-11-11","kind":"tax_withholding","acquired":false,"shares":632,"price":72.61,"value":45889.52,"ownership":{"direct":true},"balance_after":66908,"source":{"system":"sec-edgar","filing":"0001127602-21-029115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221029115/form4.xml","form_type":"4"}},{"id":2518598,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-11-10T21:33:08.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":20803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 8, 2021."}],"balance_after":20803,"derivative":{"exercise_price":71.13,"expiration_date":"2031-11-08","underlying":"Common Stock","underlying_shares":20803},"source":{"system":"sec-edgar","filing":"0001127602-21-028820","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221028820/form4.xml","form_type":"4"}},{"id":2518597,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2021-11-10T21:33:08.000Z","date":"2021-11-09","kind":"tax_withholding","acquired":false,"shares":590,"price":71.26,"value":42043.4,"ownership":{"direct":true},"balance_after":67540,"source":{"system":"sec-edgar","filing":"0001127602-21-028820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221028820/form4.xml","form_type":"4"}},{"id":2518596,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2021-11-10T21:33:08.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":6150,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":68130,"source":{"system":"sec-edgar","filing":"0001127602-21-028820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221028820/form4.xml","form_type":"4"}},{"id":2527485,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2021-11-03T20:25:28.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":28764,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Performance stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":61980,"source":{"system":"sec-edgar","filing":"0001127602-21-028279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760221028279/form4.xml","form_type":"4"}},{"id":2947469,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":9236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":37.64,"expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":9236},"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2947468,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":7633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015."}],"balance_after":0,"derivative":{"exercise_price":39.96,"expiration_date":"2025-11-05","underlying":"Common Stock","underlying_shares":7633},"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2947467,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":9236,"price":73.994,"value":683408.584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $73.98 to $74.01 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":33216,"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2947466,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":9236,"price":37.64,"value":347643.04,"ownership":{"direct":true},"balance_after":42452,"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2947465,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":7633,"price":73.995,"value":564803.835,"ownership":{"direct":true},"balance_after":33216,"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2947464,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-12-14T21:44:37.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":7633,"price":39.96,"value":305014.68,"ownership":{"direct":true},"balance_after":40849,"source":{"system":"sec-edgar","filing":"0001127602-20-031285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220031285/form4.xml","form_type":"4"}},{"id":2959426,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-12-03T22:07:44.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":5450,"price":69.63,"value":379483.5,"ownership":{"direct":true},"balance_after":33216,"source":{"system":"sec-edgar","filing":"0001127602-20-030463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220030463/form4.xml","form_type":"4"}},{"id":2980316,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-11-16T21:34:10.000Z","date":"2020-11-12","kind":"tax_withholding","acquired":false,"shares":598,"price":70.2,"value":41979.6,"ownership":{"direct":true},"balance_after":38666,"source":{"system":"sec-edgar","filing":"0001127602-20-029139","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220029139/form4.xml","form_type":"4"}},{"id":2985052,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-11-12T22:41:09.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":17512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 9, 2020."}],"balance_after":17512,"derivative":{"exercise_price":68.35,"expiration_date":"2030-11-09","underlying":"Common Stock","underlying_shares":17512},"source":{"system":"sec-edgar","filing":"0001127602-20-028859","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220028859/form4.xml","form_type":"4"}},{"id":2985051,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-11-12T22:41:09.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":632,"price":69.84,"value":44138.88,"ownership":{"direct":true},"balance_after":39264,"source":{"system":"sec-edgar","filing":"0001127602-20-028859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220028859/form4.xml","form_type":"4"}},{"id":2985050,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-11-12T22:41:09.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":5120,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":39896,"source":{"system":"sec-edgar","filing":"0001127602-20-028859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220028859/form4.xml","form_type":"4"}},{"id":2993564,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-11-04T22:37:43.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Performance stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":34776,"source":{"system":"sec-edgar","filing":"0001127602-20-028178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220028178/form4.xml","form_type":"4"}},{"id":3143954,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-05-19T20:09:03.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":13888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, August 13, 2014."}],"balance_after":0,"derivative":{"exercise_price":26.01,"expiration_date":"2021-08-13","underlying":"Common Stock","underlying_shares":13888},"source":{"system":"sec-edgar","filing":"0001127602-20-017145","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220017145/form4.xml","form_type":"4"}},{"id":3143953,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-05-19T20:09:03.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":13888,"price":51.514,"value":715426.432,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $51.28 to $51.64 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":17026,"source":{"system":"sec-edgar","filing":"0001127602-20-017145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220017145/form4.xml","form_type":"4"}},{"id":3143952,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2020-05-19T20:09:03.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":13888,"price":26.01,"value":361226.88,"ownership":{"direct":true},"balance_after":30914,"source":{"system":"sec-edgar","filing":"0001127602-20-017145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760220017145/form4.xml","form_type":"4"}},{"id":3355135,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2019-12-03T21:12:49.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":658,"price":51.32,"value":33768.56,"ownership":{"direct":true},"balance_after":17026,"source":{"system":"sec-edgar","filing":"0001127602-19-034117","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219034117/form4.xml","form_type":"4"}},{"id":3355134,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2019-12-03T21:12:49.000Z","date":"2019-12-01","kind":"tax_withholding","acquired":false,"shares":494,"price":51.32,"value":25352.08,"ownership":{"direct":true},"balance_after":17684,"source":{"system":"sec-edgar","filing":"0001127602-19-034117","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219034117/form4.xml","form_type":"4"}},{"id":3373721,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-11-13T22:21:16.000Z","date":"2019-11-11","kind":"grant","acquired":true,"shares":18102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 11, 2019."}],"balance_after":18102,"derivative":{"exercise_price":45.61,"expiration_date":"2029-11-11","underlying":"Common Stock","underlying_shares":18102},"source":{"system":"sec-edgar","filing":"0001127602-19-032641","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219032641/form4.xml","form_type":"4"}},{"id":3373720,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2019-11-13T22:21:16.000Z","date":"2019-11-12","kind":"tax_withholding","acquired":false,"shares":857,"price":46.15,"value":39550.55,"ownership":{"direct":true},"balance_after":18178,"source":{"system":"sec-edgar","filing":"0001127602-19-032641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219032641/form4.xml","form_type":"4"}},{"id":3373719,"issuer":{"id":12463,"kind":"organization","name":"HOLOGIC INC","symbol":"HOLX"},"owners":[{"id":26777,"kind":"person","name":"Thornal Kevin R","position":1,"cik":"0001783992","reported_name":"Thornal Kevin R","relationship":{"officer":true,"officer_title":"Div. President, Diagnostics"}}],"security":"Common Stock","published_at":"2019-11-13T22:21:16.000Z","date":"2019-11-11","kind":"grant","acquired":true,"shares":5481,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 11, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units are settled in shares of common stock on a one-for-one basis."}],"balance_after":19035,"source":{"system":"sec-edgar","filing":"0001127602-19-032641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/859737/000112760219032641/form4.xml","form_type":"4"}}]}